JP2023505169A5 - - Google Patents
Info
- Publication number
- JP2023505169A5 JP2023505169A5 JP2022533108A JP2022533108A JP2023505169A5 JP 2023505169 A5 JP2023505169 A5 JP 2023505169A5 JP 2022533108 A JP2022533108 A JP 2022533108A JP 2022533108 A JP2022533108 A JP 2022533108A JP 2023505169 A5 JP2023505169 A5 JP 2023505169A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- interferon
- agonist
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19306551.3 | 2019-12-03 | ||
| EP19306551 | 2019-12-03 | ||
| EP19306572.9 | 2019-12-04 | ||
| EP19306572 | 2019-12-04 | ||
| PCT/EP2020/083737 WO2021110561A1 (en) | 2019-12-03 | 2020-11-27 | Interferon-associated antigen binding proteins for use in treating hepatitis b infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023505169A JP2023505169A (ja) | 2023-02-08 |
| JP2023505169A5 true JP2023505169A5 (https=) | 2023-12-05 |
Family
ID=73554457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533108A Pending JP2023505169A (ja) | 2019-12-03 | 2020-11-27 | Ｂ型肝炎感染の治療における使用のためのインターフェロン会合抗原結合タンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230028476A1 (https=) |
| EP (1) | EP4069290A1 (https=) |
| JP (1) | JP2023505169A (https=) |
| KR (1) | KR20220109435A (https=) |
| CN (1) | CN115052626A (https=) |
| AU (1) | AU2020397416A1 (https=) |
| BR (1) | BR112022010425A2 (https=) |
| CA (1) | CA3163356A1 (https=) |
| IL (1) | IL293449A (https=) |
| WO (1) | WO2021110561A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230242655A1 (en) | 2019-12-03 | 2023-08-03 | Evotec International Gmbh | Interferon-associated antigen binding proteins and uses thereof |
| IL298136A (en) | 2020-05-13 | 2023-01-01 | Bonum Therapeutics Inc | Preparations of protein complexes and methods of using them |
| EP4351732A1 (en) * | 2021-06-09 | 2024-04-17 | Evotec International GmbH | Interferon-associated antigen binding proteins for use for the treatment or prevention of coronavirus infection |
| WO2024126294A1 (en) * | 2022-12-13 | 2024-06-20 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of parainfluenza virus infection |
| WO2024126293A1 (en) * | 2022-12-13 | 2024-06-20 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of respiratory syncytial virus infection |
| WO2024126289A1 (en) * | 2022-12-13 | 2024-06-20 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of influenza virus infection |
| WO2024213635A1 (en) * | 2023-04-12 | 2024-10-17 | Evotec International Gmbh | Interferon-associated antigen binding proteins for use for the treatment or prevention of hepatitis delta virus infection |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
| IL79289A (en) | 1985-07-05 | 1992-01-15 | Whitehead Biomedical Inst | Introduction and expression of foreign genetic material into keratinocytes using a recombinant retrovirus |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| US5750172A (en) | 1987-06-23 | 1998-05-12 | Pharming B.V. | Transgenic non human mammal milk |
| ATE117375T1 (de) | 1987-09-11 | 1995-02-15 | Whitehead Biomedical Inst | Transduktionsveränderte fibroblasten und ihre anwendung. |
| JP2914692B2 (ja) | 1987-12-11 | 1999-07-05 | ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ | 内皮細胞の遺伝子修飾 |
| WO1989007136A2 (en) | 1988-02-05 | 1989-08-10 | Whitehead Institute For Biomedical Research | Modified hepatocytes and uses therefor |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| ES2096750T3 (es) | 1990-10-31 | 1997-03-16 | Somatix Therapy Corp | Vectores retroviricos utiles para la terapia genica. |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| WO1994019935A1 (en) | 1993-03-09 | 1994-09-15 | Genzyme Corporation | Isolation of components of interest from milk |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| GB9524973D0 (en) | 1995-12-06 | 1996-02-07 | Lynxvale Ltd | Viral vectors |
| US6133426A (en) | 1997-02-21 | 2000-10-17 | Genentech, Inc. | Humanized anti-IL-8 monoclonal antibodies |
| US6517529B1 (en) | 1999-11-24 | 2003-02-11 | Radius International Limited Partnership | Hemodialysis catheter |
| MX2008013993A (es) * | 2006-05-03 | 2009-05-11 | Univ Colorado | Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular. |
| JP2013541937A (ja) * | 2010-08-05 | 2013-11-21 | エフ．ホフマン−ラ ロシュ アーゲー | 抗ｍｈｃ抗体−抗ウイルス性サイトカイン融合タンパク質 |
| ES2985566T3 (es) * | 2016-03-04 | 2024-11-06 | Univ Rockefeller | Anticuerpos contra CD40 con actividad agonista mejorada |
| EP3439696A4 (en) * | 2016-04-06 | 2019-12-25 | University of Washington | THERAPEUTIC VACCINE AGAINST THE HEPATITIS B VIRUS (HBV) USING THE HBV CORE ANTIGEN |
| WO2018087345A1 (en) * | 2016-11-14 | 2018-05-17 | F. Hoffmann-La Roche Ag | COMBINATION THERAPY OF AN HBsAg INHIBITOR, A NUCLEOS(T)IDE ANALOGUE AND AN INTERFERON |
| JP7676150B2 (ja) * | 2018-06-01 | 2025-05-14 | サノフイ | Ｂ型肝炎ウイルス感染を治療するための併用療法 |
-
2020
- 2020-11-27 AU AU2020397416A patent/AU2020397416A1/en active Pending
- 2020-11-27 BR BR112022010425A patent/BR112022010425A2/pt unknown
- 2020-11-27 WO PCT/EP2020/083737 patent/WO2021110561A1/en not_active Ceased
- 2020-11-27 CN CN202080095495.4A patent/CN115052626A/zh active Pending
- 2020-11-27 US US17/756,797 patent/US20230028476A1/en not_active Abandoned
- 2020-11-27 CA CA3163356A patent/CA3163356A1/en active Pending
- 2020-11-27 IL IL293449A patent/IL293449A/en unknown
- 2020-11-27 JP JP2022533108A patent/JP2023505169A/ja active Pending
- 2020-11-27 KR KR1020227022257A patent/KR20220109435A/ko active Pending
- 2020-11-27 EP EP20812046.9A patent/EP4069290A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023505169A5 (https=) | ||
| JP2018535650A5 (https=) | ||
| JP2025036561A5 (https=) | ||
| FI4045533T3 (fi) | Ihmisen monoklonaalisia vasta-aineita vakavalle akuutille koronavirus 2 -hengityselinoireyhtymälle (sars-cov-2) | |
| JP2020079252A5 (https=) | ||
| JP2022540083A5 (https=) | ||
| JP2022079549A5 (https=) | ||
| JP2012504955A5 (https=) | ||
| JP2021524267A5 (https=) | ||
| JP2010516229A5 (https=) | ||
| JP2018108081A5 (https=) | ||
| JP2018521638A5 (https=) | ||
| RU2009136677A (ru) | Рекомбинантные антитела для лечения респираторно-синцитиальных вирусных инфекций | |
| JP2023071956A5 (https=) | ||
| JP2011528902A5 (https=) | ||
| JP2017533694A5 (https=) | ||
| JP2010534478A5 (https=) | ||
| RU2011105062A (ru) | Нейтрализующие антитела против вируса гриппа а и их использование | |
| JP2006512899A5 (https=) | ||
| JP2011528901A5 (https=) | ||
| RU2012112829A (ru) | Анти-gitr-антитела | |
| JP2025032102A5 (https=) | ||
| JP2017537084A5 (https=) | ||
| RU2765878C2 (ru) | Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний | |
| JP2018522540A5 (https=) |